课题基金 / 基金详情

In Vivo Diagnosis of Gene Localization and Expression by Nuclear Medicine Modality

In Vivo Diagnosis of Gene Localization and Expression by Nuclear Medicine Modality
通过核医学方式进行基因定位和表达的体内诊断
批准号:
13670965
负责人:
NAKAMURA Kayoko
金额:
$2.56万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2003

项目摘要

项目成果

NAKAMURA Kayoko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The aim of this investigation is to develop nuclear medicine techniques for non-invasive diagnosis of gene localization and expression. Gene here means the one injected for gene therapy or the other over-expressed due to the disease. Using human epidermoid tumor cell line ; KB-31 and its mdr-1 transfected cell line ; KB-G2 carried out the study. By co-working with Dr. Donald J Hnatowich, Professor of Massachusetts Medical School, the following results were obtained;1. Antisense (AS) and sense (S) oligonucleotides related to mdr-1 were synthesized and modified (all phosphothiolated) and then, labeled with Tc-99m via MAG3 or HYNIC ligands. Tc-99m-AS and Tc-99m-S were obtained with high specific activity without loosing their antisense-binding affinity.2. KB-31 or KB-G2 were treated with AS or S, followed by incubation with Tc-99m-MIBI, which is to evaluate P-glycoprotein (mdr-1 expression) function. The KB-G2 treated with AS suppressed the P-gp function, while it was not shown in KB-G2 treated by S. KB-31 did not show any influence by treating with AS or S. These results indicated the antisense effect of AS oligonucleiotied we used.3. Tc-99m-AS was accumulated in KB-G2 but not in KB-31, while Tc-99m-S was not taken up either in KB-G2 or KB-31. These results indicated that AS was accumulated into the cell by antisense effect.4. Tc-99m-AS or Tc-99m-S was injected into the mice bearing KB-G2 or KB-31. The uptake of Tc-99m-AS in the KB-G2 tumor was significantly higher than that in the KB-31 tumors. Tc-99m-AS uptake in KB-G2 tumor was significantly higher than Tc-99m-S. These results indicated that Tc-99m-AS was localized into the mdr-1-tumors specifically by antisense erect.All these results would lead the success for the antisense imaging.
期刊论文(80)
专著(0)
科研奖励(0)
会议论文
中村 佳代子: "遺伝子と臨床核医学(9):クローン、クローニング、cDNA"臨床核医学. 35(2). 27-29 (2002)
Kayoko Nakamura:“基因与临床核医学 (9):克隆、克隆、cDNA”临床核医学 35(2) (2002)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kayoko Nakamura: "Can Tc-99m-MIBI assess MDR-modulators?"European Journal of Nuclear Medicine. 29(S1). S381 (2002)
Kayoko Nakamura:“Tc-99m-MIBI 可以评估 MDR 调节剂吗?”欧洲核医学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
中村 佳代子<分担>: "Sentinel Node Navigation-癌治療への新しい展開-センチネルリンパ節の核医学的検出に用いる放射性医薬品"金原出版株式会社. 296 (2002)
Kayoko Nakamura <贡献者>:“前哨淋巴结导航 - 癌症治疗的新进展 - 用于前哨淋巴结核医学检测的放射性药物” Kanehara Publishing Co., Ltd. 296 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
中村 佳代子: "医療現場は科学の実地教育現場-放射線医学教育を通して科学的な考え方を育てる-"広領域教育. 52. 53-57 (2003)
Kayoko Nakamura:“医疗场所是实用的科学教育场所 - 通过放射学教育发展科学思维”广泛学科教育。52. 53-57 (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
79
    Optical and Nuclear Imaging of Tumor-related genes
    • 批准号:
      19591434
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      NAKAMURA Kayoko
    • 依托单位:
    Gene Imaging for Studying Pharmacokinetics of Gene in Vivo at the Real Time
    • 批准号:
      16591225
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2004
    • 负责人:
      NAKAMURA Kayoko
    • 依托单位:
    Development of Nuclear Medicine Modality for Selecting Cancer Therapy and for Predicting Therapeutic Efficacy from Molecular Biological Points of View
    • 批准号:
      11670912
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      1999
    • 负责人:
      NAKAMURA Kayoko
    • 依托单位:
    Modification of Multidrug Resistance by Magnetic Exposure Indicated from the Point of View of Nuclear Medicine
    • 批准号:
      09670954
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      1997
    • 负责人:
      NAKAMURA Kayoko
    • 依托单位:
    国内基金
    海外基金
    基于中国散裂中子源伴生质子束的医用同位素Tc-99m产生研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      敬罕涛
    • 依托单位:
    表面修饰碳纳米管对Tc-99m同位素分离纯化性能的影响研究
    用于肿瘤诊断和个性化治疗的Tc-99m/Re-188标记的σ2受体放射性药物研究
    • 批准号:
      21471019
    • 项目类别:
      面上项目
    • 资助金额:
      80.0万元
    • 批准年份:
      2014
    • 负责人:
      贾红梅
    • 依托单位:
    Tc-99m标记的σ2受体肿瘤分子探针的研究
    • 批准号:
      21071023
    • 项目类别:
      面上项目
    • 资助金额:
      35.0万元
    • 批准年份:
      2010
    • 负责人:
      贾红梅
    • 依托单位: